# FDA Inspection 1210857 - Recipharm Uppsala AB - August 26, 2021

Source: https://www.globalkeysolutions.net/records/fda_inspections/recipharm-uppsala-ab/01365d0d-fa46-4ce2-a64f-92a09f907d57
Source feed: FDA_Inspections

> FDA Inspection 1210857 for Recipharm Uppsala AB on August 26, 2021. Classification: Voluntary Action Indicated (VAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1210857
- Company Name: Recipharm Uppsala AB
- Inspection Date: 2021-08-26
- Classification: Voluntary Action Indicated (VAI)
- Project Area: Drug Quality Assurance
- Product Type: Drugs
- Office Name: Center for Drug Evaluation and Research

## Related Documents

- [FDA Inspection 1301930 - 2024-04-17](https://www.globalkeysolutions.net/records/fda_inspections/recipharm-uppsala-ab/3eaa37b0-c60d-42c2-962d-34d43dbbe3cf)
- [FDA Inspection 1028387 - 2017-06-30](https://www.globalkeysolutions.net/records/fda_inspections/recipharm-uppsala-ab/3cf2f7c1-c42d-4c91-b17e-8bcde754b9ef)
- [FDA Inspection 869566 - 2014-03-14](https://www.globalkeysolutions.net/records/fda_inspections/recipharm-uppsala-ab/ffd92d1c-9662-4635-94ff-0d3dfafc5d64)

Company: https://www.globalkeysolutions.net/companies/recipharm-uppsala-ab/2b5e3c54-3326-4cac-8628-6dc7236eb53f

Office: https://www.globalkeysolutions.net/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c